BlackRock Investment Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $100K | Buy |
19,164
+121
| +0.6% | +$631 | ﹤0.01% | 3242 |
|
|
2016
Q3 | $480K | Buy |
19,043
+7
| +0% | +$176 | ﹤0.01% | 3048 |
|
|
2016
Q2 | $471K | Buy |
19,036
+1,160
| +6% | +$28.7K | ﹤0.01% | 3082 |
|
|
2016
Q1 | $518K | Buy |
17,876
+289
| +2% | +$8.37K | ﹤0.01% | 2880 |
|
|
2015
Q4 | $653K | Buy |
17,587
+203
| +1% | +$7.54K | ﹤0.01% | 2871 |
|
|
2015
Q3 | $847K | Buy |
17,384
+1,336
| +8% | +$65.1K | ﹤0.01% | 2711 |
|
|
2015
Q2 | $1.11M | Buy |
16,048
+15,420
| +2,455% | +$1.06M | ﹤0.01% | 2686 |
|
|
2015
Q1 | $22K | Buy |
628
+164
| +35% | +$5.75K | ﹤0.01% | 3414 |
|
|
2014
Q4 | $6K | Hold |
464
| – | – | ﹤0.01% | 3866 |
|
|
2014
Q3 | $7K | Buy |
464
+41
| +10% | +$619 | ﹤0.01% | 3807 |
|
|
2014
Q2 | $11K | Buy |
+423
| New | +$11K | ﹤0.01% | 3598 |
|